Effectiveness and safety of ceftazidime-avibactam plus aztreonam vs. cefiderocol for infections due to ceftazidime-avibactam-resistant Enterobacterales and Pseudomonas aeruginosa: a single-center cohort study.
- DOI
- 10.1007/s15010-026-02932-6
- Published
- 2026 Aug 25
- Container
- Infection
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s15010-026-02932-6,
title = {Effectiveness and safety of ceftazidime-avibactam plus aztreonam vs. cefiderocol for infections due to ceftazidime-avibactam-resistant Enterobacterales and Pseudomonas aeruginosa: a single-center cohort study.},
author = {Mohammad S and Ghazal H and El Daly E and Alkhateeb F and Dawoud T and Al Hassani Z and Saleem A and Al Hassani A and Almangour TA},
year = {2026},
journal = {Infection},
doi = {10.1007/s15010-026-02932-6},
url = {https://doi.org/10.1007/s15010-026-02932-6}
}RIS
TY - JOUR TI - Effectiveness and safety of ceftazidime-avibactam plus aztreonam vs. cefiderocol for infections due to ceftazidime-avibactam-resistant Enterobacterales and Pseudomonas aeruginosa: a single-center cohort study. AU - Mohammad S AU - Ghazal H AU - El Daly E AU - Alkhateeb F AU - Dawoud T AU - Al Hassani Z AU - Saleem A AU - Al Hassani A AU - Almangour TA PY - 2026 JO - Infection DO - 10.1007/s15010-026-02932-6 UR - https://doi.org/10.1007/s15010-026-02932-6 ER -
APA
S, M., H, G., E, E. D., F, A., T, D., Z, A. H., A, S., A, A. H., & TA, A. (2026). Effectiveness and safety of ceftazidime-avibactam plus aztreonam vs. cefiderocol for infections due to ceftazidime-avibactam-resistant Enterobacterales and Pseudomonas aeruginosa: a single-center cohort study.. Infection. https://doi.org/10.1007/s15010-026-02932-6
Source records
- pubmed · retrieved 2026-09-26T10:10:17.151Z
- europe-pmc · retrieved 2026-09-26T10:10:17.163Z